Merck
CN
Search Within

402-46-0

Applied Filters:
Keyword:'402-46-0'
Showing 1-1 of 1 result for "402-46-0" within Papers
F Dhainaut et al.
Vox sanguinis, 104(2), 115-126 (2012-09-26)
To compare in vitro and in vivo biological and biochemical properties of five liquid intravenous immunoglobulin (IVIg) preparations licensed for therapeutic use in Europe. ClairYg(®) was compared in a blinded manner to four other liquid IVIg preparations licensed in Europe
Page 1 of 1